Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Looking for ALISKIREN FUMARATE [WHO-DD]? Find Parenteral used in ALISKIREN FUMARATE [WHO-DD] to address drug delivery challenges on PharmaCompass.

Excipients
Parenteral
ALISKIREN FUMARATE [WHO-DD]

Emulsion
Injectable / Parenteral
Nasal Solution
Ophthalmic Solution
Solution
Suspension

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

View Presentation

Inke S.A: APIs manufacturing plant.

Contact Supplier

xyz-pharma-m-Default-Wallpaper

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

xyz-pharma-m-Default-Wallpaper

Contact Supplier

ALISKIREN FUMARATE [WHO-DD]

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 4 USDMF, 3 EU WC, 3 NDC API, 4 Listed Suppliers

9 API Suppliers
4 USDMF
3 EU WC
3 NDC API
4 Listed Suppliers

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 20 FDA Orange Book, 4 Europe

24 FDF Dossiers
20 FDA Orange Book
4 Europe

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE
TABLET;ORAL - EQ 300MG BASE
TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 6 DKSH, 2 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 22 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 16 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 27 Controlled & Modified Release, 20 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 18 Direct Compression, 17 Granulation, 13 Solubilizers, 12 Lubricants & Glidants, 8 Film Formers & Plasticizers, 7 Co-Processed Excipients, 7 Topical, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Emulsifying Agents, 4 Rheology Modifiers, 2 Parenteral

44 Coating Systems & Additives
31 Fillers, Diluents & Binders
27 Controlled & Modified Release
20 Thickeners and Stabilizers
18 Disintegrants & Superdisintegrants
18 Direct Compression
17 Granulation
13 Solubilizers
12 Lubricants & Glidants
8 Film Formers & Plasticizers
7 Co-Processed Excipients
7 Topical
6 Chewable & Orodispersible Aids
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Emulsifying Agents
4 Rheology Modifiers
2 Parenteral

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 4 Regulatory FDF Prices, 1 Annual Reports

3 US Medicaid Prescriptions
4 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

1 APIs, 1 FDF Dossiers

1 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 2 Health Canada Patents

14 US Patents
2 Health Canada Patents

Xls

Filters

Reset all filters

ALISKIREN FUMARATE [WHO-DD]

Filters

FILTER :

filter Company Reset all filters

13 All

01 13BASF

filter Capability Reset all filters

13 All

01 2Capsule

02 2Emulsion

03 1Granule / Pellet

04 2Softgel Capsule

05 2Solution

06 2Tablet

07 2Transdermal patches

filter Country Reset all filters

13 All

01 13Germany

01

BASF

AACR Annual meeting

Not Confirmed

BASF

Germany

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Transdermal patches

Grade :

Brand Name : Kollidon 17 PF

Application : Parenteral, Solubilizers

Excipient Details : Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Pharmacopoeia Ref : Ph. Eur., USP: Povidone; JPE: ...

Technical Specs :

Ingredient(s) : Povidone

Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Transdermal patches

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Povidone

Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Transdermal patches

Category : Parenteral, Solubilizers

Brand : KOLLIDON 17 PF

Applications : Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Pharmacopoeia Ref : Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specs : Not Available

Grade : Not Available

Excipients Web Link

Digital Content

02

BASF

AACR Annual meeting

Not Confirmed

BASF

Germany

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Capsule, Emulsion, Granule / Pellet, Softgel Capsule, Solution, Tablet, Transdermal patches

Grade :

Brand Name : Kollidon 12 PF

Application : Parenteral, Solubilizers

Excipient Details : Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Pharmacopoeia Ref : Ph. Eur., USP, JP

Technical Specs :

Ingredient(s) : Povidone

Dosage Form : Capsule, Emulsion, Granule / Pellet, Softgel Capsule, Solution, Tablet, Transdermal patches

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Povidone

Dosage Form : Capsule, Emulsion, Granule / Pellet, Softgel Capsule, Solution, Tablet, Transdermal patches

Category : Parenteral, Solubilizers

Brand : KOLLIDON 12 PF

Applications : Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Pharmacopoeia Ref : Ph. Eur., USP, JP

Technical Specs : Not Available

Grade : Not Available

Excipients Web Link

Digital Content

Privacy policy
Terms and conditions
Disclaimers
Ask Us!